| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.3% | 1.3% |
| ROCE | 0.9% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | 71.6 |
| PEG | n/a | n/a |
| Pr/Revenue | 0.8 | 0.7 |
| Pr/Book | 15.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 2.0% | 3.2% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-07 | 25.74 | (25.76) | (28.40)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-08 | 31.02 | (20.24) | (24.80)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-09 | 37.76 | (11.44) | (14.35)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Jun-10 | 40.75 | (0.12) | 0.20p | 57.5 | n/a | n/a | n/a | 0.0% |
| 30-Jun-11 | 41.55 | (2.31) | (0.86)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Jun-12 | 42.90 | 0.57 | 0.11p | 71.6 | n/a | n/a | n/a | 0.0% |
| 30-Jun-13 | 47.55 | 2.28 | 0.46p | 17.1 | 0.1 | +318% | n/a | 0.0% |
Copyright © 2012 FactSet Research Systems Inc. All rights reserved.
| Voluntary recall of Anapen by Lincoln Medical | 23-May-2012 | 11:23 | RNS |
| Holding(s) in Company | 17-May-2012 | 16:51 | RNS |
| Holding(s) in Company | 17-May-2012 | 16:51 | RNS |
| Allergy gets FDA lift | 26-Apr-2011 | ShareCast |
| London close: Flat day for FTSE 100 | 28-Mar-2011 | ShareCast |
| London afternoon: Shares mark time | 28-Mar-2011 | ShareCast |
| Allergy drug firm hit by trials setback | 12-Jul-2007 | The Independent |
| Need to Know: Global Business Briefing | 25-Mar-2006 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 7.88p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 15.63p |
| 52 Week Low | 7.74p |
| Volume | 50,221,642 |
| Shares Issued | 406.91m |
| Market Cap | £32.04m |
| Beta | 0.27 |
| RiskGrade | 148 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 16:39 | 10,000 @ 8.00p |
| 16:30 | 16,732,764 @ 7.74p |
| 16:28 | 10,000 @ 8.00p |
| 16:19 | 16,732,764 @ 7.75p |
| 16:19 | 16,732,764 @ 7.75p |
| Finance Director | Ian D Postlewaite |
| CEO | Manuel Llobet |
You are here: research